Austin Research Center for Retina

The trials here

What the 21 trials at this site are about, from their registry records.

Conditions

• Macular degeneration14 trials
• Diabetic eye disease7 trials

Phase

• Phase 312 trials
• Phase 24 trials
• Phase 1/23 trials
• Phase 2/31 trial

Status

• Active, not recruiting10 trials
• Completed7 trials
• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Jaeb Center for Health Research3 trials
• 4D Molecular Therapeutics2 trials
• Hoffmann-La Roche2 trials
• Kodiak Sciences Inc2 trials
• Alcon Research1 trial
• and 11 more

Running trials

• Recruiting

  A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

  NCT07867080· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Recruiting

  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  NCT07440225· Phase 2/3· EyeBiotech Ltd.· Source

  Contact: Study Coordinator

• Recruiting

  Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  NCT06790784· Phase 3· Jaeb Center for Health Research· Source

  Contact: Chirag Jhaveri, MD

• Active, not recruiting

  4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT06864988· Phase 3· 4D Molecular Therapeutics· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· Phase 3· Ocular Therapeutix, Inc.· Source

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

  NCT06556368· Phase 3· Kodiak Sciences Inc· Source

• Active, not recruiting

  A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

  NCT06510816· Phase 3· Annexon, Inc.· Source

• Active, not recruiting

  Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT05769153· Phase 1/2· Alcon Research· Source

• Active, not recruiting

  Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

  NCT05904028· Phase 3· Jaeb Center for Health Research· Source

• Active, not recruiting

  Phase 1/2 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

  NCT06087458· Phase 1/2· Perceive Biotherapeutics, Inc.· Source

• Active, not recruiting

  Fenofibrate for Prevention of DR Worsening

  NCT04661358· Phase 3· Jaeb Center for Health Research· Source

• Active, not recruiting

  A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

  NCT04108156· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease2 recruiting
• Macular degeneration2 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

  NCT06270836· Phase 3· Kodiak Sciences Inc· Source

• Completed

  QA102 Phase II Study in Subjects With Dry AMD

  NCT05536752· Phase 2· Smilebiotek Zhuhai Limited· Source

• Completed

  Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)

  NCT05447650· i-Lumen Scientific, Inc.· Source

• Completed

  A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

  NCT05230537· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

  NCT04722991· Phase 2· Bayer· Source

• Completed

  Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

  NCT04567303· Phase 1/2· Hoffmann-La Roche· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Oxurion· Source